Clinical Trial Update: Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer

View source ↗

Summary

A clinical trial by Singlera Genomics is evaluating polygenic methylation markers for monitoring postoperative recurrence in colorectal cancer; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Singlera Genomics Inc. | Conditions: Colorectal Cancer | Status: ACTIVE_NOT_RECRUITING